Prevalence of cryoglobulinemia and autoimmunity markers in renal-transplant patients

Clinical Nephrology

Volumn 69, Issue 4, 2008, Pages 239-243

  Faguer, S ^a   Kamar, N ^a   Boulestin, A ^b   Esposito, L ^a   Durand, D ^a   Blancher, A ^b   Rostaing, L ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b CHU RANGUEIL   (France)

Author keywords

Autoimmunity; Cryoglobulinemia; Cyclosporine; Kidney transplantation; Tacrolimus

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCINEURIN INHIBITOR; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; CYCLOSPORIN A; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; RAPAMYCIN; RHEUMATOID FACTOR; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD EXAMINATION; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; CREATININE CLEARANCE; CRYOGLOBULINEMIA; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY EXAMINATION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER EXAMINATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR;

EID: 42049108819     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69239     Document Type: Article

References (18)

1. Anis S, Muzaffar R, Ahmed E et al. Cryoglobulinaemia and autoimmune markers in hepatitis C virus infected patients on renal replacement therapy. J Pak Med Assoc. 2007; 57: 225-229.
2. Basse G, Ribes D, Kamar N et al. Rituximab therapy for de novo, mixed cryoglobulinemia in renal transplant patients. Transplantation. 2005; 80: 1560-1564.
3. Basse G, Ribes D, Kamar N et al. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients. Transplant Proc. 2006; 38: 2308-2310.
4. Brouet JC. Cryoglobulinemias. Presse Med. 1983; 12: 2991-2996.
5. Cacoub P, Fabiani FL, Musset L et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 1994; 96: 124-132.
6. Dammacco F, Sansonno D, Cornacchiulo V et al. Hepatitis C virus infection and mixed cryoglobulinemia: a striking association. Int J Clin Lab Res. 1993; 23: 45-49.
7. Kallemuchikkal U, Gorevic PD. Evaluation of cryoglobulins. Arch Pathol Lab Med. 1999; 123: 119-125.
8. Molina-Garrido MJ, Guillen-Ponce C. A revision on cryoglobulinaemia associated to neoplastic diseases. Clin Transplant Oncol. 2007; 9: 229-236.
9. Musset L, Diemert MC, Taibi F et al. Characterization of cryoglobulins by immunoblotting. Clin Chem. 1992; 38: 798-802.
10. Quartuccio L, Soardo G, Romano G et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford). 2006; 45: 842-846.
11. Roccatello D, Baldovino S, Rossi D et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant. 2004; 19: 3054-3061.
12. Rostaing L, Oksman F, Izopet J et al. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C. Am J Nephrol. 1996; 16: 478-483.
13. Rostaing L, Modesto A, Cisterne JM et al. Serological markers of autnimmunity in renal transplant patients with chronic hepatitis C. Am J Nephrol. 1998; 18: 50-56.
14. Sens YA, Malafronte P, Souza JF et al. Cryoglobulinemia in kidney transplant recipients. Transplant Proc. 2005; 37: 4273-4275.
15. Tedeschi A, Barate C, Minola E et al. Cryoglobulinemia. Blood Rev. 2007; 21: 183-200.
16. Trendelenburg M, Schifferli JA. Cryoglobulins in chronic hepatitis C virus infection. Clin Exp Immunol. 2003; 133: 153-155.
17. Weiner SM, Thiel J, Beig T et al. Impact of in vivo complement activation and cryoglobulins on graft outcome of HCV-infected renal allograft recipients. Clin Transplant. 2004; 18: 7-13.
18. Wu MJ, Lan JL, Shu KH et al. Prevalence of subclinical cryoglobulinemia in maintenance hemodialysis patients and kidney transplant recipients. Am J Kidney Dis. 2000; 35: 52-57.